Publication Beamlines Strategic Pillar
Abbas, Kamel (2019). Apparatus for production of molybdenum-99. Patent Number: IL242695B. Materials
Douglas ULLRICH (2024). Janela de saída de um acelerador linear para feixe de elétrons, para uso na produção de radioisótopos, sistemas e métodos. Patent Number: BR112019015503. Materials
Douglas ULLRICH (2019). Exit window for electron beam in isotope production. Patent Number: AU2018212953. Materials
William Diamond; Vinay NAGARKAL; Mark de JONG; Christopher REGIER; Linda Lin et al. (2024). APPARATUS FOR PRODUCING MOLYBDENUM-99 (99MO) FROM A PLURALITY OF MOLYBDENUM-100 (100MO) TARGETS BY A PHOTO-NUCLEAR REACTION ON THE 100MO TARGETS. Patent Number: BR112015029336B1. Materials
William Diamond; Vinay NAGARKAL; Mark de JONG; Christopher REGIER; Linda Lin et al. et al. (2019). Apparatus for production of molybdenum-99. Patent Number: IL242695. Materials
Томас ШПРЕТЕР ФОН КРЕДЕНШТАЙН; Сержит Бхимарао ДИКСИТ; Эрик ЭСКОБАР-КАБРЕРА; Пола Ирэн ЛАРИО; Дэвид Кай Юэнь ПУН et al. (2023). DEVELOPMENT OF STABLE HETERODIMERIC ANTIBODY WITH MUTATIONS IN Fc DOMAIN. Patent Number: RU2810540C2. Health
Folgueira Judit Anido; Johan Fransson; Jean Philippe Julien; Swetha Raman; Suarez Joan Seoane et al. (2025). Antibodies against lif and uses thereof. Patent Number: NZ755004B2. Agriculture
(2024). Exit Window for Electron Beam in Isotope Production. Patent Number: IL268283B2.
(2019). Prolactin receptor binding proteins and uses thereof. Patent Number: IL239502B.
(2021). Methods for improving response to anti-lif antibody treatment in individuals with cancer. Patent Number: IL279484A.
(2023). CORE/CASING ENGINEERING WITH GAPS (CSVE) OF CATALYST FOR ELECTROCHEMICAL CO2 REDUCTION. Patent Number: PT3791010T.
(2020). Combination of lif inhibitors and pd-1 axis inhibitors for use in treating cancer. Patent Number: IL277918A.
(2021). Combination of lif inhibitors and platinum-based antineoplastic agents for use in treating cancer. Patent Number: IL279444A.
(2021). ANTIBODY. Patent Number: PT3311170T.
(2024). Antibodies that bind to a complex containing TNF from the TNF superfamily and a small molecule that is its modulator. Patent Number: IL256099B2.